An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Additional Metadata
Persistent URL,
Journal Leukemia
Ossenkoppele, G.J. (G. J.), Breems, D.A. (D. A.), Stuessi, G. (G.), van Norden, Y, Bargetzi, M, Biemond, B.J, … Kuball, J. (2020). Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0). Leukemia. doi:10.1038/s41375-020-0994-7